Otol Neurol:COVID-19大流行对听力损失成人的沟通和医疗服务的影响

2021-06-23 AlexYang MedSci原创

COVID-19大流行病已经在全球范围内产生了巨大的社会、经济和健康影响。已经面临健康和医疗保健不平等的弱势成人群体可能会受到这一全球大流行病的消极影响。成年人中的使用助听器或人工耳蜗的耳聋或重听(D

COVID-19大流行病已经在全球范围内产生了巨大的社会、经济和健康影响。已经面临健康和医疗保健不平等的弱势成人群体可能会受到这一全球大流行病的消极影响。成年人中的使用助听器或人工耳蜗的耳聋或重听(DHH)的成人可能存在着沟通和医疗保健方面的潜在障碍。有证据表明,与大流行有关的通信手段、商业惯例的变化和公共卫生建议对DHH人群产生了重大影响。

患有听力损失的成年人有可能受到大流行病的消极影响。特定的因素,如听力损失的严重程度和居住地点,在大流行期间可能会对患者产生不成比例的影响。近期,有研究人员根据听力设备类型和居住地点,评估了COVID-19大流行病对听力损失患者的相对影响

研究是意向前瞻性横断面问卷研究。在三级转诊中心中进行,包括了有听力损失的成年人。数据包括了社会人口学数据、交流挑战、大流行病的预防、获得医疗服务的机会以及心理和情绪健康。

研究共有614名患者作出了回应(回应率为27.8%)。与助听器使用者相比,人工耳蜗使用者报告在大流行期间与家人/朋友沟通(53%对41%,p=0.017)、获取大流行信息(10%对3%,p=0.002)和理解现场广播(47%对17%,p=0.001)方面有更多困难。CI用户与助听器用户相比更不可能寻求普通医疗服务(52%对69%,p=0.001)和听力保健服务(20%对34%,p=0.002)。与城市居民相比,农村居民在大流行期间与朋友/家人沟通(53%对39%,p=0.001)、获得食物/用品(41%对20%,p=0.004)、理解现场广播(31%对20%,p=0.001)等方面都有较大困难。与城市居民相比,农村居民报告在获得一般的医疗服务(57%对42%,p=0.004)和听力保健(49%对34%,p=0.043)方面有更大的困难。农村居民报告的心理/情绪健康也比城市居民差。

COVID-19大流行期间医疗服务使用情况

综上所述,在有听力损失的成年人中,人工耳蜗使用者和农村居民在COVID-19大流行期间,在沟通、大流行病的预防和获得医疗保健方面遇到了更大的挑战

原始出处:

Harper L Wilson , Jacob Crouch, Marissa Schuh et al. Impacts of the COVID-19 Pandemic on Communication and Healthcare Access for Adults With Hearing Loss. Otol Neurol. May 2021

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2001380, encodeId=7b2b2001380bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 16 06:22:13 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303673, encodeId=8f8a13036e3aa, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306673, encodeId=61e313066e335, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976419, encodeId=f2a29e641962, content=有效沟通!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Jun 24 07:24:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976360, encodeId=32639e636032, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Wed Jun 23 22:42:58 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-07-16 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2001380, encodeId=7b2b2001380bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 16 06:22:13 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303673, encodeId=8f8a13036e3aa, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306673, encodeId=61e313066e335, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976419, encodeId=f2a29e641962, content=有效沟通!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Jun 24 07:24:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976360, encodeId=32639e636032, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Wed Jun 23 22:42:58 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2001380, encodeId=7b2b2001380bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 16 06:22:13 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303673, encodeId=8f8a13036e3aa, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306673, encodeId=61e313066e335, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976419, encodeId=f2a29e641962, content=有效沟通!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Jun 24 07:24:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976360, encodeId=32639e636032, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Wed Jun 23 22:42:58 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-25 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=2001380, encodeId=7b2b2001380bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 16 06:22:13 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303673, encodeId=8f8a13036e3aa, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306673, encodeId=61e313066e335, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976419, encodeId=f2a29e641962, content=有效沟通!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Jun 24 07:24:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976360, encodeId=32639e636032, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Wed Jun 23 22:42:58 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-24 学医无涯

    有效沟通!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2001380, encodeId=7b2b2001380bb, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Fri Jul 16 06:22:13 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1303673, encodeId=8f8a13036e3aa, content=<a href='/topic/show?id=90fa35013c4' target=_blank style='color:#2F92EE;'>#医疗服务#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35013, encryptionId=90fa35013c4, topicName=医疗服务)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=da20314, createdName=lfcmxl, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306673, encodeId=61e313066e335, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri Jun 25 13:22:13 CST 2021, time=2021-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976419, encodeId=f2a29e641962, content=有效沟通!, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b7a31928393, createdName=学医无涯, createdTime=Thu Jun 24 07:24:13 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976360, encodeId=32639e636032, content=了解, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuOgo3iaicb1Imgk1yIfnvr6oXzibcAFB6puAyNJXbzWhNuLqaFYBVRWjh7rghkvFLPxMAfD5ib3nXwVD/0, createdBy=bed21972958, createdName=wxl882001, createdTime=Wed Jun 23 22:42:58 CST 2021, time=2021-06-23, status=1, ipAttribution=)]
    2021-06-23 wxl882001

    了解

    0

相关资讯

Int J Pediatr Otorhinolaryngol:小儿双侧感音神经性听力损失的成像:计算机断层扫描与磁共振成像的诊断结果比较

每1000名儿童中至少有一名出生时就患有双侧感音神经性听力损失(BSNHL)。对儿童感音神经性听力损失的早期诊断和评估至关重要,以便进行早期的康复治疗。在评估小儿感音神经性听力损失时,影像学起着不可或

盘点:近期听力损失的治疗进展(七)

【1】Eur Arch Otorhinolaryngol:单侧耳硬化症手术中的双耳静噪效果研究

Ear Hear:与非高斯噪声有关的职业性听力损失:系统回顾和元分析

听力损失是全世界最普遍的感官残疾,而噪音是导致听力损失的最常见的风险因素之一。噪声引起的听力损失(NIHL)是一个全球性的公共卫生问题,职业性NIHL占成人致残性听力损失的7-21%。例如,美国职业性

Eur Arch Otorhinolaryngol:牙髓干细胞分化为内耳毛细胞能力的研究

在哺乳动物中,耳蜗毛细胞的生成大多发生在胚胎发育期,细胞在出生后不久就会成熟。与非哺乳动物不同的是,哺乳动物的耳蜗毛细胞在出生后不能再生,如果出生后发生耳蜗毛细胞损伤,就可能引起永久性的听力损失,即感

Otol Neurotol:小儿突发性感音神经性聋的放射学检查结果

突发性聋指突然发生原因不明的感音神经性听力损失,可1-2天内从轻度听力减退发展至严重的听力损失。该病的发病诱因众多,多与劳累、紧张、情绪波动、心血管疾病、血脂高、糖尿病以及天气变化相关。这些诱发原因可

PLoS One:汉族人群中TAB2多态性与噪声诱发听力损失的遗传关联研究

噪声诱发的听力损失(NIHL)归类为感音神经性听力缺陷的一种形式,是世界上职业病负担的主要贡献者。据报道,NIHL患者出现抑郁症状的可能性较大。据估计,几乎三分之一的病例可归因于噪声暴露,全世界超过1